Sinopharm Group Co. Ltd.
SHTDF | OTC
$2.01
$0.00 (0.00%)
Nov 2, 2026, 9:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 7.62 | 8.85 | 6.31 | 6.42 | 5.55 | 6.87 |
PEG Ratio | 5.74 | -0.40 | 1.01 | 0.67 | 0.71 | -0.19 |
PS Ratio | 0.09 | 0.11 | 0.10 | 0.10 | 0.08 | 0.11 |
PB Ratio | 0.65 | 0.79 | 0.77 | 0.80 | 0.69 | 0.88 |
P/FCF Ratio | 4.35 | 6.52 | 3.85 | 2.95 | 6.09 | 5.44 |
P/OCF Ratio | 3.85 | 5.41 | 3.33 | 2.61 | 4.62 | 4.43 |
OCF/S Ratio | 2.46 | 1.98 | 2.88 | 3.80 | 1.79 | 2.44 |
Debt / Equity Ratio | 1.29 | 0.97 | 0.99 | 1.02 | 1.10 | 1.22 |
Quick Ratio | 1.15 | 1.14 | 1.15 | 1.10 | 1.09 | 1.08 |
Current Ratio | 1.41 | 1.39 | 1.39 | 1.36 | 1.33 | 1.31 |
Asset Turnover | 1.47 | 1.49 | 1.56 | 1.51 | 1.55 | 1.47 |
Interest Coverage | 6.97 | 5.92 | 6.84 | 5.85 | 5.25 | 5.19 |
Return on Equity | 8.52% | 8.94% | 12.14% | 12.53% | 12.54% | 12.75% |
Return on Assets | 1.83% | 1.79% | 2.36% | 2.34% | 2.31% | 2.31% |
Return on Invested Capital | 5.63% | 5.82% | 7.83% | 8.63% | 8.76% | 8.42% |
Dividend Yield | 3.89% | 4.35% | 4.48% | 4.28% | 5.01% | 3.78% |
Payout Ratio | 29.66% | 38.51% | 28.26% | 27.45% | 27.75% | 25.95% |
FCF Payout Ratio | 16.95% | 28.34% | 17.25% | 12.62% | 30.53% | 20.53% |
Gross Profit Margin | 7.25% | 7.57% | 8.13% | 8.59% | 8.45% | 8.83% |
Net Profit Margin | 1.24% | 1.21% | 1.52% | 1.54% | 1.49% | 1.57% |
Pretax Profit Margin | 2.57% | 2.40% | 3.27% | 3.36% | 3.26% | 3.42% |
Operating Profit Margin | 2.79% | 2.77% | 3.39% | 3.73% | 3.78% | 3.89% |
FCF Margin | 2.18% | 1.64% | 2.49% | 3.36% | 1.35% | 1.99% |
EBITDA Margin | 3.35% | 3.45% | 4.51% | 4.75% | 4.74% | 4.96% |
Add to Watchlist
Select watchlists to add or remove SHTDF